Hongguo Zhao

A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP

Hai Zhou, Miao Xu, Ping Qin et al. · Blood · 2015 · 111 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +8

LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway

Xue Shi, Zhongguang Cui, Xiaodan Liu et al. · Biochemical and Biophysical Research Communications · 2019 · 110 citations

Medicine, Molecular Biology, Oncology +12

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Yafei Yu, Miaomiao Wang, Yu Hou et al. · American Journal of Hematology · 2020 · 61 citations · Full text

Medicine, Hematology, Pharmacology +8

Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

Lu Sun, Juan Wang, Linlin Shao et al. · The Lancet Haematology · 2021 · 59 citations

Medicine, Immunology, Pharmacology +7

Effectiveness of estrogen treatment before transcervical resection of adhesions on moderate and severe uterine adhesion patients

Ai-Zhen Liu, Hongguo Zhao, Ying Gao et al. · Gynecological Endocrinology · 2016 · 46 citations

Medicine, Gynecology, Surgery +17